semaglutide fda approved Approves Oral as First GLP-1 Pill for Weight Loss FDA has approved a new,

Based on Lilly's precedent with tirzepatide, retatrutide will likely receive separate brand names for different indications: Tirzepatide became Mounjaro for type 2 diabetes and Zepbound for obesity Retatrutide is expected to follow the same pattern with distinct brand names per indication Brand names are typically announced closer to the FDA approval date or during the NDA review period

GLP-1 receptors exist not just in your gut but also in your brain, particularly in the areas tied to reward and motivation

Injectable semaglutide has the longest real-world track record and a well-characterised cardiovascular benefit profile

GHK-Cu also shows cytoprotective effects in the gastrointestinal tract

FAQ How long will it take to achieve my weight loss goals after starting my weight loss treatment